These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3539806)

  • 1. Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae.
    Straus DC
    Infect Immun; 1987 Jan; 55(1):44-8. PubMed ID: 3539806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence.
    Domenico P; Diedrich DL; Straus DC
    Can J Microbiol; 1985 May; 31(5):472-8. PubMed ID: 3891056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of a lipopolysaccharide-containing extracellular toxic complex in infections produced by Klebsiella pneumoniae.
    Straus DC; Atkisson DL; Garner CW
    Infect Immun; 1985 Dec; 50(3):787-95. PubMed ID: 3905614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.
    Riottot MM; Fournier JM; Jouin H
    Infect Immun; 1981 Jan; 31(1):71-7. PubMed ID: 7012008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.
    Riottot M; Fournier JM; Pillot J
    Infect Immun; 1979 May; 24(2):476-82. PubMed ID: 378855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity.
    Tomás JM; Benedí VJ; Ciurana B; Jofre J
    Infect Immun; 1986 Oct; 54(1):85-9. PubMed ID: 3531020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A murine monoclonal antibody against Klebsiella capsular polysaccharide is opsonic in vitro and protects against experimental Klebsiella pneumoniae infection.
    Trautmann M; Cryz SJ; Sadoff JC; Cross AS
    Microb Pathog; 1988 Sep; 5(3):177-87. PubMed ID: 3063912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization against fatal experimental Klebsiella pneumoniae pneumonia.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1986 Nov; 54(2):403-7. PubMed ID: 3533779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of an extracellular toxic complex by various strains of Pseudomonas cepacia.
    Straus DC; Lonon MK; Woods DE; Garner CW
    J Med Microbiol; 1989 Sep; 30(1):17-22. PubMed ID: 2778792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum.
    Ciurana B; Tomás JM
    Infect Immun; 1987 Nov; 55(11):2741-6. PubMed ID: 3312009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the polysaccharide and of the lipopolysaccharide in the immunoprotective capacity of Klebsiella pneumoniae ribosomes.
    Robert D; Normier G; Lafont S; Dussourd d'Hinterland L; Fontanges R; Wigzell H
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):293-9. PubMed ID: 6393710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid.
    Riottot MM; Fournier JM
    Infect Immun; 1981 Oct; 34(1):126-30. PubMed ID: 6170582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further Studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. I. Production of the adjuvant polysaccharide by noncapsulated mutant.
    Ohta M; Mori M; Hasegawa T; Nagase F; Nakashima I; Naito S; Kato N
    Microbiol Immunol; 1981; 25(9):939-48. PubMed ID: 7031445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes.
    Lang AB; Bruderer U; Senyk G; Pitt TL; Larrick JW; Cryz SJ
    J Immunol; 1991 May; 146(9):3160-4. PubMed ID: 2016541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsular Polysaccharide Types and Virulence-Related Traits of Epidemic KPC-Producing Klebsiella pneumoniae Isolates in a Chinese University Hospital.
    Liu Y; Liu PP; Wang LH; Wei DD; Wan LG; Zhang W
    Microb Drug Resist; 2017 Oct; 23(7):901-907. PubMed ID: 28437231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A promising bioconjugate vaccine against hypervirulent
    Feldman MF; Mayer Bridwell AE; Scott NE; Vinogradov E; McKee SR; Chavez SM; Twentyman J; Stallings CL; Rosen DA; Harding CM
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18655-18663. PubMed ID: 31455739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
    Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
    Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and vaccine potential of Klebsiella capsular polysaccharides.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1985 Oct; 50(1):225-30. PubMed ID: 4044036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations.
    Fournier JM; Jolivet-Reynaud C; Riottot MM; Jouin H
    Infect Immun; 1981 May; 32(2):420-6. PubMed ID: 7019071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoprotective extracellular polysaccharides of Klebsiella aerogenes capsular type K1, expressed in Escherichia coli.
    Roe EA; Jones RJ; Saunders JR
    FEMS Microbiol Immunol; 1989 Apr; 1(5):253-61. PubMed ID: 2517220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.